21 CFR 520.2041
§ 520.2041 Pyrantel pamoate chewable tablets.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 520.2041, § 520.2041 Pyrantel pamoate chewable tablets, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87295
- Permanent ID
ys:prov:87295@1- SHA-256
4a2953187cbee9ac366326fe3233f67d03b81303c0cbdaed1c346b14f7788339
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each tablet contains pyrantel pamoate equivalent to 22.7 or 113.5 milligrams pyrantel base.
(b) Sponsor. See Nos. 017135 and 051311 in § 510.600(c) of this chapter.
(c) Conditions of use—(1) Amount. Provides at least 2.27 milligrams pyrantel base per pound body weight for dogs weighing more than 5 pounds, and at least 4.54 milligrams of pyrantel base per pound body weight for dogs weighing 5 pounds or less.
(2) Indications for use—(i) In dogs and puppies. For removal of ascarids (Toxocara canis; Toxascaris leonina) and hookworms (Ancylostoma caninum; Uncinaria stenocephala).
(ii) In puppies and adult dogs and in lactating bitches after whelping. To prevent reinfection of Toxocara canis.
(3) Limitations. Administer to puppies at 2, 3, 4, 6, 8, and 10 weeks of age. Administer to lactating bitches 2 to 3 weeks after whelping. Retreatment of adult dogs may be necessary at monthly intervals as determined by laboratory fecal examinations. Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.